Department of Neurosurgery, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
World Neurosurg. 2020 Nov;143:e400-e408. doi: 10.1016/j.wneu.2020.07.161. Epub 2020 Jul 31.
Microvascular decompression (MVD) is the standard surgical procedure for patients with medically refractory trigeminal neuralgia (TN). Stereotactic radiosurgery (SRS) has gained increasing popularity as a less invasive technique. We report our institution's outcome in the surgical treatment of TN (MVD vs. SRS), taking patient's age and gender into consideration.
We retrospectively reviewed a prospectively collected database of patients undergoing MVD or SRS for type 1 idiopathic TN between 2004 and 2019 at the University of Iowa. Standardized data collection focused on preoperative clinical characteristics and postoperative outcomes including the Barrow Neurological Institute (BNI) Pain Intensity Score.
A total of 111 patients underwent MVD and 103 patients underwent SRS for TN. Patients were younger in the MVD (median, 60 years) than SRS (median, 72 years) group. More females (58%) than males (42%) had TN. Multivariate ordinal regression analysis showed that an outcome of BNI score I-II (P = 0.365) and III (P = 0.736) can be achieved with either MVD or SRS; however, BNI score IV (P = 0.031) and V (P = 0.022) were more associated with SRS. Six percent of patients in the MVD group and 26% in the SRS group developed pain recurrence and required a second operation. Nine of 10 patients who underwent MVD after failed SRS had complete pain relief.
Factoring in patients' age and gender, both MVD and SRS can achieve a favorable outcome for medically refractory TN, although BNI scores of IV and V were more common with SRS.
微血管减压术(MVD)是药物难治性三叉神经痛(TN)患者的标准手术方法。立体定向放射外科(SRS)作为一种侵袭性较小的技术越来越受到关注。我们报告了我们机构在 TN 手术治疗中的结果(MVD 与 SRS),同时考虑了患者的年龄和性别。
我们回顾性分析了 2004 年至 2019 年期间在爱荷华大学接受 MVD 或 SRS 治疗 1 型特发性 TN 的前瞻性收集数据库中的患者。标准化数据收集侧重于术前临床特征和术后结果,包括巴罗神经研究所(BNI)疼痛强度评分。
共有 111 例患者接受 MVD,103 例患者接受 SRS 治疗 TN。MVD(中位数 60 岁)组患者比 SRS(中位数 72 岁)组年轻。女性(58%)多于男性(42%)患有 TN。多变量有序回归分析表明,MVD 或 SRS 均可获得 BNI 评分 I-II(P=0.365)和 III(P=0.736)的结果;然而,BNI 评分 IV(P=0.031)和 V(P=0.022)与 SRS 更相关。MVD 组中有 6%的患者和 SRS 组中有 26%的患者出现疼痛复发并需要再次手术。在 SRS 治疗失败后接受 MVD 的 10 例患者中有 9 例完全缓解疼痛。
考虑到患者的年龄和性别,MVD 和 SRS 均可为药物难治性 TN 带来良好的结果,尽管 SRS 更常见 BNI 评分 IV 和 V。